Carret & Co.

Brean Murray has published a report on EMC Corp. (NYSE: EMC). In the report, Brean Murray wrote, "For the Jun Q, we anticipate a bit of both revenue and EPS upside to Street estimates of $4.7B and $0.34, as we believe the Jun Q had a bit better tenor to it throughout (EMC reports Wed 7/20 BMO)....

Brean Murray, Carret & Co., despite its Buy and Hold ratings for The Wet Seal (NASDAQ: WTSLA) and bebe Stores, Inc. (NASDAQ: BEBE) respectively, they advise against aggressive buying of either currently. WTSLA closed at $4.23 and BEBE at $5.81 on Friday.

Brean Murray, Carret & Co. is raising its PT on Synnex Corp. (NYSE: SNX) to $43. “Contribution from the core distribution and services business – now including high value services, consumer and enterprise – and addition of ~$1.1B from newly acquired MIT (Japanese IT distribution) more than...

Avnet, Inc. (NYSE: AVT) had a solid September Q and December Q guide materially above the Street estimates, Brean Murray, Carret & Co. reports. “Sep Q EPS was $0.93 vs. Street estimate of $0.81, with Dec Q guide of $0.99-$1.07 vs. Street estimate of $0.92,” Brean Murray, Carret & Co. writes...

Brean, Murray, Carret & Co. analyst Ananda Baruah reiterated a Buy rating for shares of Xyratex Ltd. (NASDAQ: XRTX), with a price target of $24 per share. Baruah recommended buying aggressively during unwarranted sell-offs of Xyratex Ltd. stock. The analyst noted that shares of Xyratex Ltd....

Brean, Murray, Carret & Co. analyst Ingrid Yin maintained her Buy rating for shares of China Biologic Products, Inc. (Nasdaq: CBPO) and raised the price target to $20 per share, from the previous price target of $19. The analysts said that China Biologic Products, Inc. had announced that the...